State Street’s Zura Bio ZURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.16M Buy
194,963
+38,600
+25% +$233K ﹤0.01% 3457
2025
Q4
$819K Buy
156,363
+12,000
+8% +$47.5K ﹤0.01% 3568
2025
Q3
$625K Hold
144,363
﹤0.01% 3610
2025
Q2
$152K Sell
144,363
-377,929
-72% -$452K ﹤0.01% 3894
2025
Q1
$674K Buy
522,292
+12,693
+2% +$20K ﹤0.01% 3522
2024
Q4
$1.27M Buy
509,599
+114,540
+29% +$408K ﹤0.01% 3432
2024
Q3
$1.6M Buy
395,059
+127,300
+48% +$476K ﹤0.01% 3391
2024
Q2
$937K Buy
267,759
+53,011
+25% +$216K ﹤0.01% 3482
2024
Q1
$552K Buy
214,748
+23,738
+12% +$84.1K ﹤0.01% 3619
2023
Q4
$892K Buy
191,010
+29,702
+18% +$148K ﹤0.01% 3500
2023
Q3
$1.06M Sell
161,308
-4,556
-3% -$30.5K ﹤0.01% 3517
2023
Q2
$1.36M Buy
+165,864
New +$1.33M ﹤0.01% 3529

Other funds holding ZURA

State Street's ZURA Position: Q1 2026 in Review

State Street increased its Zura Bio (ZURA) stake by 25% in Q1 2026, buying an estimated $233K and bringing the position to 194,963 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #3457.

State Street first reported a position in ZURA in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.6M in Q3 2024. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

  • State Street held 194,963 shares of Zura Bio worth $1.16M as of Q1 2026.
  • State Street bought 38,600 Zura Bio shares in Q1 2026, an estimated $233K.
  • Zura Bio made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3457 holding.
  • State Street first reported a position in Zura Bio in Q2 2023 and has held it in 12 quarters since.
  • State Street's Zura Bio position peaked at $1.6M in Q3 2024.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.